Articles in Press
Current Issue
Volume 14 (2021)
Issue 3
Issue 2
Issue 1
Volume 13 (2020)
Volume 12 (2019)
Volume 11 (2018)
Volume 10 (2017)
Abaza, S. (2021). Recent advances in identification of potential drug targets and development of novel drugs in parasitic diseases. Part I: Drug resistance. Parasitologists United Journal, 14(3), 244-260. doi: 10.21608/puj.2021.103436.1141
Sherif Abaza. "Recent advances in identification of potential drug targets and development of novel drugs in parasitic diseases. Part I: Drug resistance". Parasitologists United Journal, 14, 3, 2021, 244-260. doi: 10.21608/puj.2021.103436.1141
Abaza, S. (2021). 'Recent advances in identification of potential drug targets and development of novel drugs in parasitic diseases. Part I: Drug resistance', Parasitologists United Journal, 14(3), pp. 244-260. doi: 10.21608/puj.2021.103436.1141
Abaza, S. Recent advances in identification of potential drug targets and development of novel drugs in parasitic diseases. Part I: Drug resistance. Parasitologists United Journal, 2021; 14(3): 244-260. doi: 10.21608/puj.2021.103436.1141
Article 3,
Volume 14, Issue 3, December 2021, Page 244-260
PDF (562.93 K)
Document Type: Review Article
DOI: 10.21608/puj.2021.103436.1141
Author
Sherif Abaza 
Medical Parasitology Department, Faculty of Medicine, Suez Canal University, Ismailia, Egypt
AbstractImportant obstacles facing programs involved in eradication of tropical diseases are drug resistance and environmental aspects surrounding the infected population including poverty, inefficient healthy sewage system, and popular habits. Treatment failure is determined by either persistence of clinical manifestations after scheduled drug regimen, or occurrence of disease relapse or new infections. This means that treatment failure in clinical studies does not mean drug resistance because identified parasite’ resistance to a certain drug does not include pharmacokinetics and pharmacogenetics studies as well as host immunological assessment. Coinfections, drug-drug interactions, and environmental factors also contribute in development of drug resistance. Of note, parasite gene mutation is the main mechanism suggested for drug resistance. The present work aims to review commonly reported drugs associated with resistance, and the proposed genetic markers of resistance
Keywords
drug resistance;
gene mutation;
genome plasticity, mechanism of resistance;
mode of action;
pharmacogenetics, pharmacokinetics
Statistics
Article View: 2
PDF Download: 2
Comments (0)